Vimarsana
Biggest News Aggregation in the World

Page 5 - Amanda Sheldon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amanda Sheldon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amanda Sheldon Today - Breaking & Trending Today

FDA Approves Arcutis' ZORYVE® (roflumilast) Cream 0.3% for Treatment of Psoriasis in Children ... | Region - Vimarsana News

FDA Approves Arcutis' ZORYVE® (roflumilast) Cream 0.3% for Treatment of Psoriasis in Children ... | Region

WESTLAKE VILLAGE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S.

Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia - Vimarsana News

Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia

Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit tiered royalties WESTLAKE VILLAGE, Calif. and HANGZHOU, China, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, and Hangzhou Zhongmei Huadong Pharmaceutical Co, a wholly owned subsidiary of Huad

Source: yahoo.com
Arcutis and Huadong Announce Strategic Collaboration and - Vimarsana News

Arcutis and Huadong Announce Strategic Collaboration and

Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit...

Arcutis to Report Second Quarter Financial Results - Vimarsana News

Arcutis to Report Second Quarter Financial Results

WESTLAKE VILLAGE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical...

Heated library book debate continues at EG Unified - Vimarsana News

Heated library book debate continues at EG Unified

The debate continues over whether local school libraries should remove books that some parents consider to be obscene or pornographic.